These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 18755948

  • 1. Cancer research. Can fasting blunt chemotherapy's debilitating side effects?
    Couzin J.
    Science; 2008 Aug 29; 321(5893):1146-7. PubMed ID: 18755948
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 2.
    Walker K.
    IDrugs; 2007 Aug 29; 10(8):517-9. PubMed ID: 17665321
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical use of prospidine].
    Barsel' VA, Disvetova VV, Evseenko LS, Orlova RS, Tverdynin MS.
    Vopr Onkol; 1970 Aug 29; 16(8):36-41. PubMed ID: 5501882
    [No Abstract] [Full Text] [Related]

  • 5. Regional chemotherapy for carcinoma of the lung.
    Müller H, Guadagni S.
    Surg Oncol Clin N Am; 2008 Oct 29; 17(4):895-917, xi. PubMed ID: 18722925
    [Abstract] [Full Text] [Related]

  • 6. Controlling symptoms in elderly lung cancer patients.
    J Support Oncol; 2007 Feb 29; 5(2):78-9. PubMed ID: 17348364
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Metronomic chemotherapy in pediatric oncology: hype or hope?].
    André N, Pasquier E, Verschuur A, Sterba J, Gentet JC, Rössler J.
    Arch Pediatr; 2009 Aug 29; 16(8):1158-65. PubMed ID: 19446445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Results of the clinical study of the antineoplastic preparation phenamet].
    Lichinitser MR, Garin AM, Blokhina NG, Vaarik KhM, Voznyĭ EK.
    Vopr Onkol; 1974 Aug 29; 20(5):91-2. PubMed ID: 4612985
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk-adapted use of intravesical immunotherapy.
    Braasch MR, Böhle A, O'Donnell MA.
    BJU Int; 2008 Nov 29; 102(9 Pt B):1254-64. PubMed ID: 19035890
    [No Abstract] [Full Text] [Related]

  • 16. Nanoparticle therapeutics: an emerging treatment modality for cancer.
    Davis ME, Chen ZG, Shin DM.
    Nat Rev Drug Discov; 2008 Sep 29; 7(9):771-82. PubMed ID: 18758474
    [Abstract] [Full Text] [Related]

  • 17. Limited role of cell kinetics in clinical cancer chemotherapy.
    Hall TC.
    Natl Cancer Inst Monogr; 1971 Dec 29; 34():15-7. PubMed ID: 4946579
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Help patients cope with chemo.
    Nagel T.
    RN; 2004 Oct 29; 67(10):25-6, 28-30; quiz 31. PubMed ID: 15552377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.